Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Increases By 225.0%

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 3,900 shares, a growth of 225.0% from the January 15th total of 1,200 shares. Based on an average daily volume of 14,800 shares, the days-to-cover ratio is presently 0.3 days.

BioSyent Stock Up 0.2 %

Shares of OTCMKTS BIOYF traded up $0.02 during trading hours on Wednesday, reaching $7.81. The stock had a trading volume of 391 shares, compared to its average volume of 5,103. BioSyent has a 52-week low of $5.93 and a 52-week high of $8.90. The business’s fifty day moving average price is $7.84 and its two-hundred day moving average price is $7.85.

BioSyent Cuts Dividend

The firm also recently declared a dividend, which was paid on Monday, December 16th. Stockholders of record on Monday, December 2nd were given a dividend of $0.0322 per share. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend was Friday, November 29th.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.